Studies have found that SLC7A11 is a key target gene of BAP1, and BAP1 inhibits the expression of SLC7A11 by reducing H2Aub on the SLC7A11 promoter, promoting the occurrence of ferroptosis, and then inhibiting tumor growth. This evidence concerns the gene BAP1 and neoplasm.